Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;21(1):1-5.
doi: 10.1089/dia.2018.0362. Epub 2018 Dec 21.

The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set

Affiliations

The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set

Roy W Beck et al. Diabetes Technol Ther. 2019 Jan.

Abstract

Objective: To evaluate the association of biochemical hypoglycemia with subsequent severe hypoglycemia (SH) events using the Diabetes Control and Complications Trial (DCCT) data set.

Research design and methods: The frequency of biochemical hypoglycemia (percentage of values <70 and <54 mg/dL [3.9 and 3.0 mmol/L) was assessed using DCCT blood glucose concentrations measured at a central laboratory from seven finger-stick samples (7-point testing: pre- and 90-min postmeals and at bedtime) collected during 1 day every 3 months. SH events required a change in mental status necessitating the involvement of another individual to provide treatment. A Poisson model accounting for repeated measures from each participant was used to assess the association of biochemical hypoglycemia frequency, computed from the 7-point finger-stick data, with the development of SH events.

Results: The risk of SH during a 3-month period was substantially higher (P < 0.001) when there was at least one hypoglycemic blood glucose value in the preceding 7-point profile, with similar results seen for both the 70 mg/dL (rate ratio = 3.0 [95% confidence interval: 2.6-3.3]) and 54 mg/dL (rate ratio = 2.7 [95% confidence interval: 2.4-3.1]) thresholds.

Conclusions: The occurrence of biochemical hypoglycemia <70 or <54 mg/dL is associated with an increased risk of SH. For this reason as well as the deleterious effects of hypoglycemia on glucose counter-regulation and hypoglycemia awareness, cognition, quality of life, and arrhythmias, it is important in diabetes management to avoid hypoglycemic glucose levels as much as possible.

Keywords: Biochemical hypoglycemia; Risk assessment; Severe hypoglycemia; Type 1 diabetes..

PubMed Disclaimer

Conflict of interest statement

R.W.B., T.D.R., and C.K. have no personal disclosures, but report that their institution has received research funding or study supplies from Abbott, Ascenia, Bigfoot, Dexcom, Roche, Tandem, and consulting fees from Insulet and Lilly. R.M.B. has no personal disclosures, but reports that his employer, the nonprofit Health Partners Institute, contracts for his services, which includes research support, consulting, or scientific advisory board participation for Abbott Diabetes Care, Becton Dickinson, Dexcom, Eli Lilly, Glooko, Hygieia, Johnson & Johnson, Medtronic, Merck, Novo Nordisk, Roche, and Sanofi.

Figures

<b>FIG. 1.</b>
FIG. 1.
Frequency of ≥1 SH event in a 3-month period according to the number of hypoglycemia blood glucose values in the preceding profile. SH, severe hypoglycemia.

References

    1. Agiostratidou G, Anhalt H, Ball D, et al. : Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017;40:1622–1630 - PMC - PubMed
    1. Beyond ACWG: Need for regulatory change to incorporate beyond A1C glycemic metrics. Diabetes Care 2018;41:e92–e94 - PubMed
    1. Danne T, Nimri R, Battelino T, et al. : International consensus on use of continuous glucose monitoring. Diabetes Care 2017;40:1631–1640 - PMC - PubMed
    1. International Hypoglycaemia Study G: Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2017;40:155–157 - PubMed
    1. Beck RW, Kollman C, Xing D, et al. : Outcome measures for outpatient hypoglycemia prevention studies. J Diabetes Sci Technol 2011;5:999–1004 - PMC - PubMed

Publication types